News: Featured News


Thursday, June 15, 2017   (1 Comments)
Posted by: Leila Faucette
Share |

DEA x for Prescribing Suboxone®(Buprenorphine) for Medication Assisted Treatment

Nurse Practitioners (NPs) (not all APRNs), now by federal law, are allowed to prescribe buprenorphine (Suboxone®) for medication assisted treatment for 30 patients.  The NP must meet educational requirements, obtain a CAPA-CS with a physician meeting the same requirements, and obtain a DEAx, before prescribing buprenorphine.   NPs are required to provide written notice to the Board of changes in CAPA-CS and DEA registrations. [201 KAR 20:057 (4) (b)]


Gabapentin now Controlled Substance

As of July 1, 2017, gabapentin will be classified as a Schedule V, controlled substance (in KY). APRNs must now meet prescribing requirements for controlled substances in order to prescribe gabapentin.  APRNs will no longer be able to prescribe gabapentin unless they have a DEA license and a CAPA-CS.   Prescriptions for gabapentin shall be limited to the original prescription and refills not to exceed a six (6) month supply.  Gabapentin dispensed in Kentucky will appear on KASPER reports. All Gabapentin samples must be destroyed, as controlled substances may not be provided as samples.


HB 333

New legislation, effective June 29, 2017, limits ALL prescribers, with certain exceptions, to a 72- hour supply of any Schedule II medication, if the prescription is intended to treat pain as an acute medical condition.  The law DOES affect the prescribing of hydrocodone containing prescriptions, changing prescribing authority of APRNs who currently may prescribe hydrocodone for a 30-day supply.  APRNs may only prescribe hydrocodone for 72 hours per prescription intended to treat pain as an acute medical condition, unless one of the statutory exceptions applies.  Additional new prescriptions may be written, but the law necessitates accurate and consistent documentation to justify continuing to prescribe 72-hour prescriptions of Schedule II medications, including hydrocodone.  Prescriptions may be “partially filled” by pharmacists upon request by the patient or the prescriber.

KASPER Reviews

APRNs are encouraged to conduct regular “reverse KASPER” reviews to verify that the prescriptions recorded  and attributed to the APRN prescriber’s name are correct and were indeed prescribed by the APRN.  Additionally, if prescribing outside one’s authority is noted, the APRN should self-report to the KBN that the act occurred [KRS 314.031(4)].  The APRN should review the Online Validation on the KBN website to ensure that prescribing information is on file with the KBN, e.g. CAPA-NS, Discontinuation of CAPA-NS, CAPA-CS, DEA, DEAx.  Submit to Curt Lowther, Curtwand.Lowther@KY.Gov, ph. 502-429-3329.


Please see KBN website, APRN Practice tab for additional information.


Terri Congleton RN MSN says...
Posted Thursday, June 15, 2017
Can anyone speak to HB 333? How/when did this happen? What will this affect if using to treat chronic pain? This appears to be addressing "acute" pain.

more Calendar

Regional Meeting Somerset

Regional Meeting Owensboro

Regional Meeting Ashland

Regional Meeting Ashland

Kentucky 5th Annual Viral Hepatitis Conference

Pharmacy Potpourri: Updates in the Treatment of Chronic Conditions

Association Management Software Powered by YourMembership  ::  Legal